How Clinical Data Platforms May Reshape U.S. Market Entry for Healthcare Technologies
Historically, many healthcare technologies approached the U.S. market through three familiar priorities: regulatory clearance, channel access, and commercialization execution. That logic is changing. For a growing range of AI products, advanced devices, digital health tools, and translational research equipment, U.S. market entry is increasingly being reshaped by a new variable: clinical data platforms and the real-world evidence capabilities behind them.